This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| ADMIRAL GROUP PLC | 2,238.0 | 2.6% |
| BRITISH AMERICAN TOBACCO PLC | 3,244.5 | 1.3% |
| HIKMA PHARMACEUTICALS PLC | 1,947.0 | 1.0% |
| VODAFONE GROUP PLC | 140.9 | 0.9% |
| IMPERIAL BRANDS PLC | 1,658.0 | 0.9% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| ITV PLC | 102.5 | -12.0% |
| EVRAZ PLC | 289.3 | -11.9% |
| CARNIVAL PLC | 2133.0 | -7.3% |
| TUI AG-DI | 540.4 | -7.2% |
| RIO TINTO PLC | 3648.5 | -7.1% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 6,705 | -1.6% | -6.8% |
| DOW JONES INDUS. AVG | 26,121 | -3.6% | 1.7% |
| DAX INDEX | 11,945 | -1.5% | 3.1% |
| NIKKEI 225 | 20,750 | -2.7% | -3.9% |
| S&P/ASX 200 INDEX | 6,216 | -2.8% | -0.5% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 45.60 | -0.65% |
| Brent Crude (ICE) | USD/bbl. | 49.66 | -0.66% |
| Gold Spot | USD/t oz. | 1,671 | -0.1% |
| Copper (Comex) | USd/lb. | 256 | -0.4% |
Click graph to enlarge
UK 100 called to open -130 points at 6575; The powerful rally in sovereign bonds gathered pace on Friday, sending benchmarks to historic lows and stirring unease in equities in volatile trading. Thirty-year Treasury yields slid below 1.5% for the first time, Chinese 10-year yields hit levels unseen since 2002. An all red session in Asia saw the Nikkei drop 2.72%, the Hang Seng fell by 2.4% and the Chinese CSI dropping 1.59%. Gold is heading for the biggest weekly gain since 2011, Bullion’s up 5.8% since Monday, near seven-year highs, amid a rush away from risk. Oil extended its slide from the lowest close in more than two years as investors wait for a Russian response to OPEC’s plan for deeper and longer cuts to offset the demand destruction caused by the coronavirus. Brent closed below $50 for the first time since mid-2017 on Thursday after OPEC ministers tried to force Russia into accepting a proposal.
AstraZeneca state that their Phase III DANUBE trial for Imfinzi and Imfinzi plus tremelimumab in unresectable, Stage IV (metastatic) bladder cancer did not meet the primary endpoints of improving overall survival.
Aviva announces that it has agreed to exit Indonesia by selling its entire shareholding in its joint venture in the region.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Countrywide
Funding Circle
Clarkson
Lancashire Holdings
US - Non Farm Payroll
UK 100 :
Land securities
Anglo American
CRH
:
Jupiter Fund Management
GVC holdings
Assura
Compass Group Upgraded to Buy by Morningstar (Bloomberg: 6 Buys/ 14 Holds/ 3 Sells)
Hammerson Downgraded to Neutral by Goldman Sachs (Bloomberg: 5 Buys/ 9 Holds/ 6 Sells)
Jupiter Fund Management Downgraded to Sell by Berenberg (Bloomberg: 1 Buys/ 4 Holds/ 10 Sells)
Page Group Upgraded to Buy by Numis securities (Bloomberg: 5 Buys/ 7 Holds/ 2 Sells)
Victrex downgraded to Underperform by Barclays (Bloomberg: 3 Buys/ 8 Holds/ 5 Sells)
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.